Beta blocker effects on heart rate during sleep: a placebo-controlled polysomnographic study with normotensive males.
Although the effect of beta blockers on heart rate (HR) at rest, during exercise, and by ambulatory electrocardiography during the day and night has been studied extensively, data on the effect of these drugs on heart rate during the various stages of sleep are not available. We performed overnight polysomnography and exercise testing in a randomized, double-blind, placebo-controlled, Latin square crossover study of four beta blockers with different ancillary properties (atenolol 100 mg daily, metoprolol 100 mg, pindolol 10 mg, and propranolol 80 mg), on 30 healthy men aged 23-40 years (29.4 +/- 4.3) (mean +/- SD). At rest pindolol increased HR by 4.7 beats/min +/- 13.1 (p less than 0.05), while beta blockers without intrinsic sympathomimetic activity (ISA) decreased HR (p less than 0.0001) by 6.1 +/- 8.8 (atenolol), 5.8 +/- 8.4 (propranolol), and 5.0 +/- 9.4 (metoprolol). Exercise at 125 W increased HR on placebo by 76.4 +/- 18.4 beats. Compared to placebo all beta blockers were associated with lower (p less than 0.0001) exercise HR by 18.3 +/- 23.2 atenolol, 21.1 +/- 15.5 metoprolol, 16.8 +/- 14.1 pindolol, and 20.8 +/- 13.1 propranolol [not significant (NS) among beta blockers]. Thus the effect of beta blockers on heart rate was magnified during exercise. Mean and maximum HR were higher in rapid eye movement (REM) than in nonREM (NREM) sleep (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
U.M.D.N.J.-Robert Wood Johnson Medical School, Department of Psychiatry, Piscataway 08854.
R C
RC
Rosen
J B
JB
Kostis
L G
LG
Seltzer
L S
LS
Taska
B C
BC
Holzer
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D001262:Atenolol / Q000494:pharmacology; D002540:Cerebral Cortex / Q000187:drug effects; D004311:Double-Blind Method; D004562:Electrocardiography / Q000187:drug effects; D004569:Electroencephalography / Q000187:drug effects*; D005080:Exercise Test / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D008790:Metoprolol / Q000494:pharmacology; D008991:Monitoring, Physiologic; D010869:Pindolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012894:Sleep Stages / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D011433:Propranolol; D010869:Pindolol; D008790:Metoprolol